• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于澳大利亚生殖遗传携带者筛查项目(“麦肯齐使命”)的基因选择。

Gene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission").

机构信息

Centre for Clinical Genetics, Sydney Children's Hospital Randwick, Randwick, NSW, Australia.

School of Women's and Children's Health, University of New South Wales, Randwick, NSW, Australia.

出版信息

Eur J Hum Genet. 2021 Jan;29(1):79-87. doi: 10.1038/s41431-020-0685-x. Epub 2020 Jul 16.

DOI:10.1038/s41431-020-0685-x
PMID:32678339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7852568/
Abstract

Reproductive genetic carrier screening aims to offer couples information about their chance of having children with certain autosomal recessive and X-linked genetic conditions. We developed a gene list for use in "Mackenzie's Mission", a research project in which 10,000 couples will undergo screening. Criteria for selecting genes were: the condition should be life-limiting or disabling, with childhood onset, such that couples would be likely to take steps to avoid having an affected child; and/or be one for which early diagnosis and intervention would substantially change outcome. Strong evidence for gene-phenotype relationship was required. Candidate genes were identified from OMIM and via review of 23 commercial and published gene lists. Genes were reviewed by 16 clinical geneticists using a standard operating procedure, in a process overseen by a multidisciplinary committee which included clinical geneticists, genetic counselors, an ethicist, a parent of a child with a genetic condition and scientists from diagnostic and research backgrounds. 1300 genes met criteria. Genes associated with non-syndromic deafness and non-syndromic differences of sex development were not included. Our experience has highlighted that gene selection for a carrier screening panel needs to be a dynamic process with ongoing review and refinement.

摘要

生殖遗传携带者筛查旨在为夫妇提供有关生育某些常染色体隐性和 X 连锁遗传疾病患儿的机会的信息。我们开发了一个基因列表,用于“Mackenzie's Mission”研究项目,该项目将对 10000 对夫妇进行筛查。选择基因的标准是:疾病应具有生命限制或致残性,且发病于儿童期,以便夫妇可能会采取措施避免生育受影响的孩子;和/或对于这种疾病,早期诊断和干预会显著改变结果。需要有强有力的基因表型关系证据。候选基因是从 OMIM 中确定的,并且通过对 23 个商业和已发表的基因列表进行了审查。临床遗传学家使用标准操作程序对基因进行了审查,由包括临床遗传学家、遗传咨询师、伦理学家、患有遗传疾病的儿童的父母和来自诊断和研究背景的科学家在内的多学科委员会监督了这一过程。有 1300 个基因符合标准。未包括与非综合征性耳聋和非综合征性性别发育差异相关的基因。我们的经验表明,用于携带者筛查面板的基因选择需要是一个具有持续审查和完善的动态过程。

相似文献

1
Gene selection for the Australian Reproductive Genetic Carrier Screening Project ("Mackenzie's Mission").用于澳大利亚生殖遗传携带者筛查项目(“麦肯齐使命”)的基因选择。
Eur J Hum Genet. 2021 Jan;29(1):79-87. doi: 10.1038/s41431-020-0685-x. Epub 2020 Jul 16.
2
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission): Design and Implementation.澳大利亚生殖遗传携带者筛查项目(麦肯齐使命):设计与实施
J Pers Med. 2022 Oct 28;12(11):1781. doi: 10.3390/jpm12111781.
3
Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners.孕前和产前遗传疾病携带者筛查:全科医生的关键作用。
Aust J Gen Pract. 2019 Mar;48(3):106-110. doi: 10.31128/AJGP-10-18-4725.
4
Development and use of the Australian reproductive genetic carrier screening decision aid.澳大利亚生殖遗传携带者筛查决策辅助工具的开发与应用。
Eur J Hum Genet. 2022 Feb;30(2):194-202. doi: 10.1038/s41431-021-00991-x. Epub 2021 Nov 1.
5
Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.体外受精和一般人群中管理生殖遗传风险的孕前扩展携带者筛查的临床有效性和实用性。
Hum Reprod. 2021 Jun 18;36(7):2050-2061. doi: 10.1093/humrep/deab087.
6
User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia.澳大利亚近亲夫妇全外显子生殖携带检测的用户可接受性
J Genet Couns. 2019 Apr;28(2):240-250. doi: 10.1007/s10897-018-0298-5. Epub 2018 Dec 14.
7
Views of reproductive genetic carrier screening participants regarding screening for genes associated with non-syndromic hearing loss.具有生育遗传携带者筛查史人群对筛查非综合征型听力损失相关基因的看法。
Prenat Diagn. 2022 Dec;42(13):1658-1666. doi: 10.1002/pd.6253. Epub 2022 Nov 15.
8
Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.一般人群中个体和夫妇对扩展携带者筛查的兴趣:文献系统评价。
Hum Reprod Update. 2020 Apr 15;26(3):335-355. doi: 10.1093/humupd/dmaa001.
9
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.
10
Expanded carrier screening in Chinese patients seeking the help of assisted reproductive technology.在寻求辅助生殖技术帮助的中国患者中进行扩大的携带者筛查。
Mol Genet Genomic Med. 2020 Sep;8(9):e1340. doi: 10.1002/mgg3.1340. Epub 2020 Jun 23.

引用本文的文献

1
Pathogenic variation underlying rare diseases in an Arab population: Implications for screening programs.阿拉伯人群罕见病的致病变异:对筛查项目的影响。
Genet Med Open. 2025 Jul 19;3:103446. doi: 10.1016/j.gimo.2025.103446. eCollection 2025.
2
Prospective parents' views on reproductive genetic carrier screening: "You know better, you do better".准父母对生殖遗传携带者筛查的看法:“你知道得更多,就能做得更好”。
J Genet Couns. 2025 Aug;34(4):e70100. doi: 10.1002/jgc4.70100.
3
A dataset of estimated heterozygous individual and carrier couple frequencies for pan-ancestry carrier screening.一个用于泛族裔携带者筛查的估计杂合个体和携带者夫妇频率的数据集。
Data Brief. 2025 Jun 25;61:111835. doi: 10.1016/j.dib.2025.111835. eCollection 2025 Aug.
4
Reproductive and cognitive phenotypes in carriers of recessive pathogenic variants.隐性致病变异携带者的生殖和认知表型
Nat Hum Behav. 2025 May 15. doi: 10.1038/s41562-025-02204-7.
5
Carrier screening for Alport syndrome: The clinical importance of heterozygosity for pathogenic or likely pathogenetic variants.阿尔波特综合征的携带者筛查:致病或可能致病变异杂合性的临床重要性。
J Genet Couns. 2025 Jun;34(3):e70045. doi: 10.1002/jgc4.70045.
6
The Intersection Between Genetic Reproductive Carrier Screening and Genomic Newborn Screening: Implications for Clinical Practice.基因生殖携带者筛查与基因组新生儿筛查的交叉点:对临床实践的影响。
Prenat Diagn. 2025 Sep;45(10):1277-1280. doi: 10.1002/pd.6771. Epub 2025 Mar 8.
7
Editorial: severity in a genomic age.社论:基因组时代的严重性
Eur J Hum Genet. 2025 Mar;33(2):144-146. doi: 10.1038/s41431-024-01766-w. Epub 2025 Feb 19.
8
Towards responsible ctDNA-based multi-cancer screening: a preliminary exploration and discussion of ethically relevant aspects.迈向基于ctDNA的负责任多癌筛查:对伦理相关方面的初步探索与讨论
Extracell Vesicles Circ Nucl Acids. 2022 Aug 16;3(3):235-243. doi: 10.20517/evcna.2022.23. eCollection 2022.
9
The diagnosis communication process in spinal muscular atrophy: A cross-cutting view of the new challenges facing the therapeutic era.脊髓性肌萎缩症的诊断沟通流程:治疗时代面临的新挑战的全景审视
Genet Med Open. 2023 Jul 5;1(1):100825. doi: 10.1016/j.gimo.2023.100825. eCollection 2023.
10
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening.生殖遗传携带者筛查后对严重程度的认知及其对生殖决策的影响。
Eur J Hum Genet. 2025 Mar;33(2):199-207. doi: 10.1038/s41431-024-01742-4. Epub 2024 Dec 6.

本文引用的文献

1
International perspectives on the implementation of reproductive carrier screening.生殖载体筛查实施的国际视角。
Prenat Diagn. 2020 Feb;40(3):301-310. doi: 10.1002/pd.5611. Epub 2019 Nov 29.
2
Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple-based approach and examination of couples' views.在医疗保健中进行常染色体隐性疾病的扩展携带者筛查:基于夫妇的方法的论据和对夫妇观点的考察。
Prenat Diagn. 2019 Apr;39(5):369-378. doi: 10.1002/pd.5437. Epub 2019 Feb 28.
3
Feasibility of couple-based expanded carrier screening offered by general practitioners.由全科医生提供的基于夫妇的扩展携带者筛查的可行性。
Eur J Hum Genet. 2019 May;27(5):691-700. doi: 10.1038/s41431-019-0351-3. Epub 2019 Feb 11.
4
Expanded carrier screening: A current perspective.扩展携带者筛查:当前视角
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:41-54. doi: 10.1016/j.ejogrb.2018.09.014. Epub 2018 Sep 13.
5
Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing.孕前携带者筛查基因组测序中遗传咨询的时间成本
J Genet Couns. 2018 Aug;27(4):823-833. doi: 10.1007/s10897-017-0205-5. Epub 2018 Feb 8.
6
Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.澳大利亚囊性纤维化、脆性 X 综合征和脊髓性肌萎缩症的生殖遗传携带者筛查:12000 次检测的结果。
Genet Med. 2018 Apr;20(5):513-523. doi: 10.1038/gim.2017.134. Epub 2017 Oct 26.
7
Expanded carrier screening for monogenic disorders: where are we now?扩展性携带者筛查:我们现在在哪里?
Prenat Diagn. 2018 Jan;38(1):59-66. doi: 10.1002/pd.5109. Epub 2017 Jul 27.
8
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource.评估基因与疾病关联的临床有效性:临床基因组资源开发的循证框架
Am J Hum Genet. 2017 Jun 1;100(6):895-906. doi: 10.1016/j.ajhg.2017.04.015. Epub 2017 May 25.
9
The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies.人类基因突变数据库:致力于打造一个全面的遗传性突变数据仓库,服务于医学研究、基因诊断及新一代测序研究。
Hum Genet. 2017 Jun;136(6):665-677. doi: 10.1007/s00439-017-1779-6. Epub 2017 Mar 27.
10
Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases.基于人群的孕前携带者筛查:普通人群中的潜在使用者如何看待针对50种严重疾病的检测。
Eur J Hum Genet. 2016 Oct;24(10):1417-23. doi: 10.1038/ejhg.2016.43. Epub 2016 May 11.